Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E32.44 EPS (ttm)2.27 Insider Own0.20% Shs Outstand745.45M Perf Week4.11%
Market Cap54.90B Forward P/E13.52 EPS next Y5.45 Insider Trans0.47% Shs Float743.80M Perf Month2.32%
Income1.80B PEG2.40 EPS next Q1.29 Inst Own87.70% Short Float1.93% Perf Quarter11.76%
Sales100.49B P/S0.55 EPS this Y28.30% Inst Trans-0.10% Short Ratio3.52 Perf Half Y4.33%
Book/sh26.98 P/B2.73 EPS next Y11.66% ROA3.30% Target Price79.24 Perf Year15.55%
Cash/sh3.80 P/C19.36 EPS next 5Y13.50% ROE8.10% 52W Range59.20 - 79.37 Perf YTD4.85%
Dividend- P/FCF11.65 EPS past 5Y8.40% ROI6.80% 52W High-7.21% Beta1.14
Dividend %- Quick Ratio0.50 Sales past 5Y36.50% Gross Margin7.80% 52W Low24.41% ATR1.32
Employees29975 Current Ratio0.70 Sales Q/Q-4.80% Oper. Margin3.40% RSI (14)58.55 Volatility1.86% 1.89%
OptionableYes Debt/Eq0.79 EPS Q/Q-1.50% Profit Margin1.80% Rel Volume0.65 Prev Close73.06
ShortableYes LT Debt/Eq0.59 EarningsOct 28 AMC Payout0.00% Avg Volume4.08M Price73.65
Recom2.00 SMA203.59% SMA501.09% SMA2002.16% Volume2,635,891 Change0.81%
30-Jul-14Reiterated FBR Capital Outperform $79 → $74
28-Jul-14Reiterated UBS Buy $90 → $82
01-May-14Reiterated Maxim Group Buy $92 → $90
30-Apr-14Reiterated Mizuho Buy $86 → $82
06-Mar-14Reiterated Deutsche Bank Hold $75 → $79
05-Mar-14Reiterated RBC Capital Mkts Outperform $72 → $84
05-Mar-14Initiated Barclays Overweight $85
21-Feb-14Reiterated FBR Capital Outperform $75 → $83
19-Feb-14Reiterated Maxim Group Buy $80 → $92
18-Feb-14Downgrade Monness Crespi & Hardt Buy → Neutral
17-Jan-14Reiterated Mizuho Buy $74 → $86
21-Nov-13Initiated Deutsche Bank Hold $73
24-Oct-13Initiated FBR Capital Outperform $75
31-Jul-13Reiterated Oppenheimer Outperform $65 → $74
05-Jul-13Reiterated Mizuho Buy $63 → $69
01-Jul-13Initiated Monness Crespi & Hardt Buy $78
06-Jun-13Reiterated Maxim Group Buy $70 → $80
30-Apr-13Reiterated ISI Group Neutral $57.50 → $60
12-Apr-13Reiterated UBS Buy $66 → $69
20-Feb-13Reiterated Mizuho Buy $60 → $63
24-Oct-14 06:35PM  Final Glance: Drug Benefits companies AP
01:17PM  Midday Glance: Drug Benefits companies AP
10:40AM  Early Glance: Drug Benefits companies AP
23-Oct-14 04:01PM  AmerisourceBergen's Move To Go Big Is The Right Rx at Investor's Business Daily
21-Oct-14 11:15AM  Time for a Checkup With This Health Care ETF ETF Trends
20-Oct-14 04:37PM  Will High Price Hurt Gilead Sciences' New Hep-C Drug? at Barrons.com
16-Oct-14 04:56PM  9 pro stock picks for intrepid bulls at CNBC
03:35PM  Buy these stocks now CNBC
15-Oct-14 08:52PM  F.D.A. Approves First 2 Drugs for Treatment of a Fatal Lung Disease at New York Times
07:30AM  2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality and Performance Rating PR Newswire
10-Oct-14 04:32PM  U.S. FDA approves Gilead's $94,500 hepatitis C drug Reuters
02:45PM  Harvoni, a Hepatitis C Drug From Gilead, Wins F.D.A. Approval at New York Times
09-Oct-14 04:00PM  Express Scripts Holding Company Announces Third Quarter 2014 Earnings Conference Call GlobeNewswire
08-Oct-14 07:30AM  New Express Scripts Analysis Reveals Trends Among Health Exchange Members PR Newswire
07-Oct-14 08:46PM  Health Law Drug Plans Are Given a Check-Up at New York Times
05:35PM  These 3 Upcoming IPOs Have Strong Investor Interest at Investor's Business Daily
04:05PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06-Oct-14 02:15PM  IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs at Investor's Business Daily
01:03PM  3 Stocks Dragging The Health Services Industry Downward at TheStreet
10:38AM  2 Mutual Funds Holding Hospital Stocks Benzinga
01-Oct-14 05:02PM  Mixed Economic Data, Ebola Scares Rattle Markets Benzinga
01:14PM  Walgreen to sell drugs under Express Scripts 2015 Medicare plans Reuters
08:35AM  Express Scripts 2015 Medicare drug plans to be available at Walgreen Reuters
07:30AM  Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network PR Newswire
30-Sep-14 10:01AM  As Walgreen Goes Global, U.S. Medicare Pressures Remain at Forbes
26-Sep-14 01:04PM  3 Stocks Pushing The Health Services Industry Lower at TheStreet
13-Sep-14 12:01AM  $250 Billion in Biotech Drug Savings on Brink of Arrival at Bloomberg
12-Sep-14 04:33PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:27PM  Express Scripts Elects Roderick Palmore to Board of Directors PR Newswire
11-Sep-14 10:48AM  [video] Live Nation Initiated a Buy, Bearish Calls for Macy's at TheStreet
09:29AM  UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company Benzinga
08:27AM  Analysts' Actions: Express Scripts, JDS Uniphase, Omnicare and More TheStreet
08:19AM  How Will This Analyst Downgrade Affect Express Scripts (ESRX) Stock Today? at TheStreet
08:10AM  Top Analyst Upgrades and Downgrades: JDSU, JD.com, Palo Alto, Petrobras, SeaWorld, Twitter, Yandex and More at 24/7 Wall St.
10-Sep-14 08:30PM  Stock Trading Ideas for 9/10/12 Yahoo Finance Blogs
02-Sep-14 01:03PM  WLP, UNH And ESRX, Pushing Health Services Industry Downward at TheStreet
28-Aug-14 01:04PM  3 Stocks Pulling The Health Services Industry Downward at TheStreet
27-Aug-14 06:04PM  Self-critical, Cramer reveals big stock regret at CNBC
23-Aug-14 12:01AM  Writing a Bigger Book at Barrons.com
21-Aug-14 06:00AM  Ferguson Shows U.S. Impulse to Kill Cities in Search for Growth at Bloomberg
05:53AM  Injustice in Ferguson, Long Before Michael Brown at BusinessWeek
19-Aug-14 01:05PM  Will Ferguson?s Business Community Recover from Riots, Lootings? at Fox Business
01:03PM  3 Stocks Pushing The Health Care Sector Higher at TheStreet
18-Aug-14 04:05PM  Air Methods Navigates To Grow Medical Flight Business at Investor's Business Daily
17-Aug-14 07:00AM  A Few Picks to Tide Over the Bargain-Hunters Morningstar
15-Aug-14 03:44PM  The County Map That Explains Fergusons Tragic Discord at BusinessWeek
14-Aug-14 08:37PM  Pharmacies Turn Drugs Into Profits, Pitting Insurers vs. Compounders at New York Times
03:33PM  Ferguson's economy: Tough, but signs of progress at CNNMoney.com
03:19PM  Express Scripts: A Prescription for Higher Prices Yahoo Finance Blogs
11-Aug-14 09:40AM  Deere, A Homebuilder And A Bank To Buy And Trade at Forbes
08-Aug-14 01:57PM  Inflation a 'key concern' for these companies at CNBC
01:03PM  3 Health Services Stocks On The Rise at TheStreet
05-Aug-14 04:18PM  [$$] CVS: Healthy Numbers Even as It Quits Cigarettes at Barrons.com
01:04PM  EXPRESS SCRIPTS HOLDING CO. Financials EDGAR Online Financials
08:30AM  U.S. Will Waste $9 Billion on Non-Pharmacy Specialty Medications in 2015 PR Newswire
04-Aug-14 04:18PM  Stock Market Today: Risky Complacency Brings Stocks Higher TheStreet
02:34PM  Envision Pharmaceutical Holdings, Inc. -- Moody's affirms Envision Pharmaceutical's B3 CFR; moves outlook to stable from positive at Moody's
01:03PM  Health Services Stocks On The Rise With Help From 3 Stocks at TheStreet
01:02PM  Midday movers: Amgen, Groupon, Walt Disney & more at CNBC
11:03AM  Why GlaxoSmithKline (GSK) Stock Is Higher Today at TheStreet
10:48AM  'Buy and Trade' Strategies For Qualcomm And Tidewater In A Risky Market at Forbes
07:00AM  Catamaran Sails Through Another Solid Quarter Morningstar
06:14AM  Investor stays in Express Scripts optionMONSTER
01-Aug-14 07:44PM  Express Scripts drops Amgen anemia drugs from formulary Reuters
05:12PM  Express Scripts excludes Amgen drugs from 2015 formulary Reuters
31-Jul-14 01:30PM  Drug pricing: Bitter pill at Financial Times
30-Jul-14 01:03PM  3 Stocks Pushing The Health Services Industry Higher at TheStreet
12:08PM  Express Scripts (ESRX) Stock Storming The Castle Today at TheStreet
10:00AM  Express Scripts Beats on Earnings & Sales, Adjusts Guidance Zacks
09:14AM  Will This Price Target Decrease Hurt Express Scripts (ESRX) Stock Today? at TheStreet
Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. It operates in two segments, PBM and Other Business Operations. The company's PBM services comprise retail network pharmacy administration; home delivery pharmacy; benefit design consultation; drug utilization review; drug formulary management; clinical solutions to improve health outcomes; an array of Medicare Part D, Medicaid, and health insurance marketplace; specialty pharmacy services, such as the distribution of fertility pharmaceuticals that require special handling or packaging; bio- pharmaceutical services, including reimbursement and logistics solutions; group purchasing organization administration; and consumer health and drug information services. It is also involved in the distribution of pharmaceuticals and medical supplies to providers and clinics; development of scientific evidence to guide the use of medicines; and provision of case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. Express Scripts Holding Company provides its PBM services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, and government health programs; and specialty services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
IGNACZAK EDWARD BEVPSep 05Sale75.289,886744,21675,996Sep 09 05:01 PM
STERNBERG SEYMOURDirectorAug 28Option Exercise54.3015,508842,07920,277Sep 02 04:07 PM
STERNBERG SEYMOURDirectorAug 28Sale74.1215,5081,149,3914,769Sep 02 04:07 PM
Ebling Keith J.Exec. VP and General CounselAug 25Sale75.5010,000755,00010,000Aug 26 04:04 PM
BENANAV GARY GDirectorAug 05Option Exercise35.8512,694455,01655,705Aug 07 04:08 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Option Exercise53.0520,0001,061,00049,532Aug 06 04:10 PM
BENANAV GARY GDirectorAug 05Sale70.8212,694898,98943,011Aug 07 04:08 PM
Wade Sara ESr. VP, Ch. Human Res. Off.Aug 05Sale70.4420,0001,408,80029,532Aug 06 04:10 PM
Norton David ASenior VP, Supply ChainAug 04Sale71.021,27690,6270Aug 06 04:13 PM
Breen Maura CDirectorAug 01Option Exercise35.8512,694455,01630,283Aug 05 04:55 PM
Breen Maura CDirectorAug 01Sale69.9412,694887,75517,589Aug 05 04:55 PM
PAZ GEORGEChairman & CEOJun 13Option Exercise26.68681,50818,179,3841,469,761Jun 17 05:04 PM
PAZ GEORGEChairman & CEOJun 13Sale71.21681,50848,530,185788,253Jun 17 05:04 PM
WENTWORTH TIMOTHY CPresidentMay 27Option Exercise47.25127,1896,009,516228,492May 29 05:03 PM
WENTWORTH TIMOTHY CPresidentMay 27Sale70.47105,6777,447,058122,815May 29 05:03 PM
Wimberly GarySr. VP & Ch. Information Off.Mar 13Option Exercise45.3934,5361,567,69758,157Mar 17 04:34 PM
Wimberly GarySr. VP & Ch. Information Off.Mar 13Sale78.4144,4973,489,09913,660Mar 17 04:34 PM
Houston ChristineSr. Vice President, OperationsMar 12Option Exercise31.9215,674500,31438,071Mar 14 06:24 PM
Houston ChristineSr. Vice President, OperationsMar 12Sale78.5319,7571,551,45818,314Mar 14 06:24 PM
IGNACZAK EDWARD BExec. VP, Sales and MktgMar 11Option Exercise55.14120,2476,630,559206,129Mar 13 05:42 PM
IGNACZAK EDWARD BExec. VP, Sales and MktgMar 11Sale78.54120,2479,443,83985,882Mar 13 05:42 PM
Norton David ASenior VP, Supply ChainMar 11Sale79.153,160250,123630Mar 13 05:38 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 11Sale79.009,582756,97820,000Mar 11 06:02 PM
Miller Steven BSr. VP & Chief Med. OfficerMar 10Sale77.9612,664987,29821,417Mar 12 06:05 PM
McNamee PatrickExec. VP and COOMar 10Sale78.2227,9812,188,5627,664Mar 12 06:03 PM
McNamee PatrickExec. VP and COOMar 10Sale78.3240,4443,167,69512,421Mar 12 06:03 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 07Option Exercise49.509,901490,05038,361Mar 11 06:02 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 07Option Exercise47.1437,4311,764,58363,624Mar 11 06:04 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 07Sale78.2243,7673,423,23919,857Mar 11 06:04 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 07Sale78.5016,1391,266,92822,222Mar 11 06:02 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 07Sale77.6737,6612,925,17829,582Mar 07 06:44 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 06Option Exercise49.5036,8091,821,86165,269Mar 07 06:44 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 06Sale78.5036,8092,889,54328,460Mar 07 06:44 PM
STERNBERG SEYMOURDirectorMar 05Option Exercise30.8313,128404,73616,406Mar 07 06:56 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 05Option Exercise23.81139,8623,329,652198,241Mar 07 06:44 PM
STERNBERG SEYMOURDirectorMar 05Sale76.5013,1281,004,3053,278Mar 07 06:56 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 05Sale77.0051,1163,935,9320Mar 07 06:44 PM
Ebling Keith J.Exec. VP and Gen. CounselMar 05Sale77.03169,78113,078,06128,460Mar 07 06:44 PM
ROPER WILLIAM LDirectorFeb 25Option Exercise39.0341,4961,619,56051,894Feb 27 05:14 PM
ROPER WILLIAM LDirectorFeb 25Sale74.0841,4963,073,81610,398Feb 27 05:14 PM
Houston ChristineSr. Vice President, OperationsFeb 21Option Exercise19.668,948175,93621,177Feb 25 04:46 PM